AstraZeneca Applies for Vaccine Use Approval in Japan
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2021010414272998474_1609738049.jpg)
[Asia Economy Reporter Jeon Jinyoung] British pharmaceutical company AstraZeneca applied for manufacturing and sales approval (usage approval) of its COVID-19 vaccine to Japan's Ministry of Health, Labour and Welfare on the 5th. AstraZeneca is the second company to apply for COVID-19 vaccine approval from Japanese health authorities, following Pfizer.
According to local media, the Japanese government has signed a contract with AstraZeneca to supply 120 million doses of the vaccine. The goal is to manufacture more than 90 million doses domestically in Japan.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- [Lee Jaemyung Administration 1 Year] 300,000 Benefit from Rural Basic Income, K-Food Hits 'All-Time High' Last Year
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
AstraZeneca conducted clinical trials on 256 subjects in Japan last August. The key data being prepared is scheduled to be submitted to the relevant authorities in March.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
